L&G Pharma Breakthrough

Description

This ETF tracks the Solactive Pharma Breakthrough Value index tracks companies involved in the development and manufacturing of so-called "orphan drugs". Orphan drugs are drugs that target very rare diseases. Ticker: BIGT ISIN: IE00BF0H7608

Securities

Horizon Therapeutics Plc

5.73%

Biogen Inc

4.46%

BeiGene Ltd

3.95%

United Therapeutics Corp

3.74%

Abbvie Inc

3.63%

View all 33 >>>

Regions

North America - 49.77%

Europe ex-UK - 32.70%

Asia ex-Japan - 7.28%

Japan - 6.28%

Rest of the World - 3.98%

Sectors

Healthcare - 60.49%

Financial - 3.46%

Technology - 2.90%

Industrial - 2.64%

Sector ‐ Other - 30.51%